Clinical Trial Update: A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating the effects of repeat dosing of GW870086X in adults with mild to moderate asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW870086X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED